Sagoh
Tokyo, Japan – June 14, 2024 – The highly anticipated film trilogy adaptation of the cult classic anime Mononoke finds itself embroiled in controversy following the surprise return of the original Medicine Seller, voiced by Takahiro Sakurai, in the recently released third installment, Mononoke The Movie: Chapter III – The Curse of the Serpent. The decision, made without prior announcement, has ignited a passionate debate among fans and led to the abrupt retirement of the franchise’s planning producer, Kōji Yamamoto.
The revelation that Sakurai, whose controversial personal scandal led to his replacement in the film trilogy, had reprised his iconic role for a cameo in the third film, Mononoke The Movie: Chapter III – The Curse of the Serpent (also known as Gekijōban Mononoke Dai-San-Shō: Hebigami), only came to light after the movie’s theatrical debut on May 29th. This lack of transparency has been met with a mixed reaction, polarizing the fanbase and prompting a public apology from Kōji Yamamoto, who simultaneously announced his departure from producing.
A Shocking Return and a Fanfare of Discontent
The Mononoke film trilogy, a sprawling cinematic endeavor intended to delve deeper into the mysterious world of the exorcist, has captivated audiences with its unique aesthetic and psychological horror. The first two films, Mononoke The Movie: Chapter I – Capturing the Phantom and Mononoke The Movie: Chapter II – The Matchlock Monster, were released with significant anticipation. However, it was the third and final chapter, Chapter III – The Curse of the Serpent, that would inadvertently become the focal point of fan outrage and industry discussion.
Upon the film’s release, eagle-eyed and attentive fans quickly recognized the familiar voice of the original Medicine Seller, a character central to the beloved television series that predates the film trilogy. This realization was compounded by the fact that this original iteration of the Medicine Seller was not the protagonist of the film trilogy; that role had been assumed by a new Medicine Seller, voiced by Hiroshi Kamiya, following the casting change. The appearance of the original Medicine Seller was a surprise cameo, and the staff’s decision to withhold this information from the public prior to the film’s opening generated significant backlash.
The absence of any pre-release announcement regarding Sakurai’s return fueled a firestorm on social media platforms and fan forums. While some fans expressed delight at hearing Sakurai’s iconic portrayal once more, others felt betrayed and confused, particularly given the circumstances surrounding his previous removal from the trilogy. This divisive reaction underscored a fundamental disagreement on how such a sensitive casting decision should have been handled.
Following the widespread discussion and criticism, the production team released a new trailer for Chapter III – The Curse of the Serpent on June 10th. The trailer prominently featured the original Medicine Seller character delivering a line, yet it notably omitted any mention of the voice actor. This continued reticence, even after the initial controversy erupted, only served to further inflame the situation, leaving many to question the motivations behind the secrecy.
Kōji Yamamoto’s Apology and Producer’s Retirement
In a candid and somber post on his X (formerly Twitter) account on Friday, June 14th, planning producer Kōji Yamamoto addressed the controversy head-on. He offered a sincere apology to the fans for the manner in which the information about the Medicine Seller’s cameo was managed. More significantly, Yamamoto announced his decision to retire from his role as a producer.
"I take full responsibility for the way this information was handled," Yamamoto stated in his post, acknowledging the distress and confusion caused to the Mononoke fanbase. His decision to step down marks the end of an era for him within the franchise and signals a significant shift in the production landscape.
Yamamoto’s apology delved into the creative process behind the controversial decision. He explained that during the story development for the third film, the staff grappled with how to best conclude the narrative, particularly concerning the antagonist. It was during these discussions that the idea of summoning a "different Medicine Seller" emerged. Yamamoto clarified that while they could have opted for a new character, the team felt a strong desire to respond to the persistent calls from fans who wished for the return of the original Medicine Seller from the television series, often referred to as the "Ri" Medicine Seller.
"We believed we could bring back the character in a ‘good way’ to please fans and make those happy who wanted to see the character again," Yamamoto elaborated, revealing a perceived intent to create a moment of nostalgic joy for long-time followers of the series.
However, Yamamoto admitted that his strategy of allowing fans to experience the reunion "without knowing about it beforehand" was ultimately flawed. He explained that the decision to only reveal the character’s appearance and Sakurai’s involvement three days after the film’s opening was intended to preserve the surprise. Yet, he conceded, "by doing it that way, it ‘deprived those who did not want to see the original Medicine Seller to choose on their own whether they wanted to go see the film or not.’" This admission highlights a critical miscalculation in understanding the diverse expectations and sensitivities within the fanbase. His apology for this "lack of consideration" was a direct acknowledgment of the unintended consequences of his approach.
Moving forward, Yamamoto stated his intention to shift his focus to "management and training the next generation." This suggests a desire to contribute to the industry in a mentorship capacity rather than direct project production. His extensive career as a producer boasts a notable list of critically acclaimed anime titles, including anohana: The Flower We Saw That Day, The Ancient Magus’ Bride, Eden of the East, Lu over the wall, Princess Jellyfish, Psycho-Pass, ZENSHU., and The Tatami Galaxy, underscoring his significant contributions to the animation world.
Chronology of Events: From Scandal to Surprise Return
The current controversy is deeply intertwined with the personal and professional fallout from a scandal involving Takahiro Sakurai. Understanding this history is crucial to comprehending the complexity of the recent decisions and fan reactions.
October 2022: The Japanese tabloid newspaper Weekly Bunshun published a report alleging that Takahiro Sakurai had been engaged in a decade-long extramarital affair with a writer for his travel radio show, P.S. Genki Desu. Takahiro. The report further detailed that the writer was reportedly unaware of Sakurai’s marital status until shortly before the final episode of the show was recorded. Sakurai had maintained discretion about his marriage until September 2022, when he confirmed his marital status to the press. The scandal caused significant public outcry and professional repercussions for Sakurai.
February 2023: Following the revelations and the subsequent public fallout, Twin Engine, the production company behind the Mononoke film trilogy, announced a delay to the first film. In a statement, they revealed that Takahiro Sakurai would no longer be reprising his planned role as the Medicine Seller for the trilogy. The company cited the narrative’s focus on the suffering and remedy of women as the reason for the casting change, stating, "Judging from the standpoint of the story, we decided to change the cast of the Medicine Seller." This decision marked a significant shift, with Hiroshi Kamiya subsequently taking over the role of the film trilogy’s protagonist Medicine Seller, a character distinct from the original television series’ protagonist.
May 29, 2024: Mononoke The Movie: Chapter III – The Curse of the Serpent, the third and final installment of the film trilogy, premiered in Japan. The film featured a surprise cameo by the original Medicine Seller, voiced by Takahiro Sakurai, without any prior announcement from the production staff.
June 1, 2024 (approximate): News of Sakurai’s cameo began to circulate among theatergoers, leading to widespread discussion and debate online.
June 10, 2024: Twin Engine released a new trailer for Chapter III – The Curse of the Serpent. The trailer included a voice line from the original Medicine Seller but did not credit the voice actor.
June 14, 2024: Kōji Yamamoto, planning producer for the Mononoke franchise, posted an apology on his X account regarding the handling of the Medicine Seller’s return and announced his retirement from producing.
Supporting Data: The Impact of the Scandal and the Casting Decision
The decision to replace Sakurai in 2023 was a direct response to the serious allegations and the ensuing public relations crisis. The statement from Twin Engine, referencing the film’s narrative focus on women’s experiences, suggested a calculated move to distance the project from the controversy and ensure that the thematic integrity of the story was not compromised by the association with Sakurai’s personal scandal. This move was widely understood as a necessary step to safeguard the franchise’s reputation and appeal to a broader audience, particularly given the sensitive nature of the themes explored in Mononoke.
The subsequent decision to bring Sakurai back for a cameo in the third film, without transparency, appears to be a stark contradiction of the earlier stance. While Yamamoto’s explanation points to a desire to appease long-time fans who cherished Sakurai’s original portrayal, the execution of this decision has proven to be highly divisive. The controversy highlights the delicate balance producers must strike between creative intentions, fan expectations, and the ethical considerations surrounding public figures involved in personal scandals.
The fact that the original Medicine Seller is a distinct character from the protagonist of the film trilogy further complicates the situation. This implies that the cameo was intended as a nod to the franchise’s history, a bridge between the past and the present cinematic iteration. However, the method of its implementation has overshadowed any potential nostalgic appreciation, instead generating a significant debate about professional conduct, artistic integrity, and the management of public perception.
Official Responses and Future Implications
The primary official response has come in the form of Kōji Yamamoto’s apology and retirement announcement. His willingness to take responsibility and step down signifies the gravity of the situation from the production’s perspective. The apology acknowledges that the method of revelation was a misstep, potentially alienating segments of the audience and creating unnecessary conflict.
Twin Engine, as the primary production entity, has remained relatively silent beyond Yamamoto’s statement and the initial casting change announcement in 2023. Their continued silence following the recent controversy suggests a strategy of allowing Yamamoto to address the immediate fallout while they potentially re-evaluate their communication protocols for future projects.
The implications of this controversy are multifaceted. For the Mononoke franchise, it has cast a shadow over the conclusion of what was intended to be a triumphant film trilogy. While the films themselves may still be critically acclaimed for their artistic merit, the behind-the-scenes drama will likely be a significant talking point for the foreseeable future.
For Takahiro Sakurai, the situation remains complex. His return to a prominent role, even as a cameo, in a major anime production following a public scandal raises questions about the industry’s willingness to reintegrate figures who have faced significant personal criticism. While fans are divided, the controversy has undeniably brought his personal life back into the public spotlight in relation to his professional work.
On a broader level, this incident serves as a case study in modern fan engagement and the perils of opaque decision-making in the entertainment industry. In an era of instant communication and heightened public scrutiny, surprise reveals, especially those involving controversial figures, require meticulous planning and a deep understanding of audience sentiment. The Mononoke case underscores the importance of transparency, respectful communication, and a nuanced approach to navigating the intersection of personal conduct and professional output. The future of the Mononoke franchise, and how it will be perceived by its dedicated fanbase, will undoubtedly be shaped by how effectively these lessons are learned and applied moving forward.
Asro
Neng Nana
